How is the GH Research PLC today?

The GH Research PLC today is trading in the down by -5.18% at 11.89.

How has GH Research PLC performed historically?

The GH Research PLC is currently trading down -5.18% on an intraday basis in the past week the index fell -0.83%. The index has been down -7.69% in the past quarter and rose 0.34% in the past year. You can view this in the overview section.

What is GH Research PLC Annual Net Profit?

GH Research PLC Annual Net Profit fell 9.48% in the last year to $38.96 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is GH Research PLC Price to Earning Ratio?

GH Research PLC Price to Earning Ratio is -17.52, which is negative.

What is GH Research PLC Stock Price?

GH Research PLC Stock Price rose 0.34% and underperformed its sector by 60.16% in the past year.

What is GH Research PLC Quarterly Net profit?

GH Research PLC Quarterly Net profit fell 41.04% YoY to $10.81 M. Its sector's average net profit growth YoY for the quarter was -236.03%.

What is GH Research PLC Debt to Equity Ratio?

GH Research PLC Debt to Equity Ratio is zero as the company is debt-free.

What is GH Research PLC Return on Equity(ROE)?

GH Research PLC Return on Equity(ROE) for the last financial year was -19.58%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is GH Research PLC Mutual Fund Holding?

GH Research PLC Mutual Fund Holding increased by 0.94% in the last quarter to 8.02.

What is GH Research PLC Interest Coverage Ratio?

GH Research PLC Interest Coverage Ratio is -810.69, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is GH Research PLC Institutional Holding?

GH Research PLC Institutional Holding increased by 15.63% in the last quarter to 57.31.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
GH RESEARCH PLC

GH Research PLC XNAS: GHRS

GH Research PLC Live Share Price Today, Share Analysis and Chart

Name: GH Research PLC: Is Infosys Ltd. worth buying?
Item: GH Research PLC
Rating: 1.81816675
Author: Trendlyne DVM scores

about

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...

11.89 -0.65 (-5.18%)

42.00% Fall from 52W High

146.9K

XNAS Volume

XNAS 25 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for GH Research PLC is on 27 Jun 2025 for the purpose of GH Research PLC Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

7.7 / 100

Technically Moderately Bullish

65.1 / 100

No estimates available

GH Research PLC Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

GH Research PLC Live Share Price Today, Share Analysis and Chart

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies f...

42.00% Fall from 52W High

SWOT Analysis

GH Research PLC Live Price Chart

GH Research PLC FAQ

How is GH Research PLC today?

GH Research PLC today is trading in the red, and is down by -5.18% at 11.89.

How has GH Research PLC performed historically?

GH Research PLC is currently trading down -5.18% on an intraday basis. In the past week the stock fell -0.83%. stock has been down -7.69% in the past quarter and rose 0.34% in the past year. You can view this in the overview section.